Acetaminophen/Caffeine/Ephedrine Hydrochloride/Diphenhydramine Hydrochloride

对乙酰氨基酚/咖啡因/盐酸麻黄碱/盐酸苯海拉明

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAcetaminophen/Caffeine/Ephedrine Hydrochloride/Diphenhydramine Hydrochloride
Drug Alias Name复方氨酚苯海拉明
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists +[5] 
TargetsCyclooxygenasesAdenosine A1 receptorAdenosine A2a receptor +[5] 
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AcetaminophenCaffeineEphedrine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ05AX
Related LinksN/A